Coming May/June 2021
18% CBG, 0.00% THC. The first THC-free hemp strain to be introduced to Canada.
Panakeia is a feminized hemp variety naturally developed through selective breeding containing no THC (0.00%) and a high concentration of Cannabigerol (CBG, up to 18%), the precursor to Cannabidiol (CBD). No more risk of “hot hemp” with spikes in THC content.
As this is a feminized variety, nearly 100% of planted seeds yields a female plant from which flower can be harvested for medicinal use. Currently, there is a paucity of hemp varieties approved by Health Canada that are feminized, which impacts yield and cost.
Although research is still in its infancy, the health effects of CBG have been reported to be similar to that of CBD, including treating pain, reducing inflammation and acting as a neuroprotective agent.
Panakeia has been developed through collaboration with our partners at Hemp Trading and the University of Valencia. We hold the rights for the registration and distribution of Panakeia in Canada, as well as the exclusive rights for the sale of seeds, clones and plant matter in Ontario, Canada.